Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Bremelanotide (Vyleesi) for hypoactive sexual desire disorder.

[No authors listed]

Med Lett Drugs Ther. 2019 Jul 29;61(1577):114-116. Review. No abstract available.

PMID:
31381550
2.

Sexual arousal: Sex matters.

Petherick A.

Nature. 2017 Oct 4;550(7674):S2-S3. doi: 10.1038/550S2a. No abstract available.

PMID:
28976951
3.

Phase I Randomized Placebo-controlled, Double-blind Study of the Safety and Tolerability of Bremelanotide Coadministered With Ethanol in Healthy Male and Female Participants.

Clayton AH, Lucas J, DeRogatis LR, Jordan R.

Clin Ther. 2017 Mar;39(3):514-526.e14. doi: 10.1016/j.clinthera.2017.01.018. Epub 2017 Feb 9.

4.

Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial.

Clayton AH, Althof SE, Kingsberg S, DeRogatis LR, Kroll R, Goldstein I, Kaminetsky J, Spana C, Lucas J, Jordan R, Portman DJ.

Womens Health (Lond). 2016 Jun;12(3):325-37. doi: 10.2217/whe-2016-0018. Epub 2016 May 16.

6.

Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.

Nelson ME, Bryant SM, Aks SE.

Clin Toxicol (Phila). 2012 Dec;50(10):1169-73. doi: 10.3109/15563650.2012.740637. Epub 2012 Nov 5.

PMID:
23121206
7.

Gateways to clinical trials.

Tomillero A, Moral MA.

Methods Find Exp Clin Pharmacol. 2008 Oct;30(8):643-72.

PMID:
19088949
8.

Salvage of sildenafil failures with bremelanotide: a randomized, double-blind, placebo controlled study.

Safarinejad MR, Hosseini SY.

J Urol. 2008 Mar;179(3):1066-71. doi: 10.1016/j.juro.2007.10.063. Epub 2008 Jan 18.

PMID:
18206919
9.

Gateways to clinical trials.

Bayes M, Rabasseda X, Prous JR.

Methods Find Exp Clin Pharmacol. 2006 Dec;28(10):719-40.

PMID:
17235418

Supplemental Content

Loading ...
Support Center